Myeloablative Allogeneic Bone Marrow Transplant Using T Cell Depleted Allografts Followed by Post-Transplant GM-CSF in High Risk Myelodysplastic Syndromes

Allogeneic blood and marrow transplantation (alloBMT) remains the only curative treatment for patients with myelodysplastic syndromes (MDS), but its application has been limited by the older age range of patients with this disease. T cell depletion decreases transplant-related toxicity related to gr...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Warlick, Erica D., O'Donnell, Paul V., Borowitz, Michael, Grupka, Nichon, Decloe, Lauren, Garrett-Mayer, Elizabeth, Borrello, Ivan, Brodsky, Robert, Fuchs, Ephraim, Huff, Carol Ann, Luznik, Leo, Matsui, William, Ambinder, Richard, Jones, Richard J., Smith, B. Douglas
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2008
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2719785/
https://ncbi.nlm.nih.gov/pubmed/18261793
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2007.12.017
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi